-
Solentim wins place in Deloitte UK Technology Fast 50
Nov 16, 2018, 08:03 AM by Michael CroftWIMBORNE, UK - Nov 16, 2018 - Wimborne, UK, 16th November 2018 / Sciad Newswire / Solentim, a life sciences company, has won a place in this year's Deloitte's UK Technology Fast 50 list following a 1,106% revenue growth over the past 4 yearsFull story -
Elsevier launches Entellect™ Platform, unlocking value by creating AI-ready life sciences data
Nov 15, 2018, 07:53 AM by Michael CroftNEW YORK, NY, UNITED STATES - Nov 15, 2018 - Elsevier, the information analytics business specializing in science and health, today announced the launch of Entellect, a new cloud-based data platform designed to help life sciences companies overcome the challenges of modern R&D by enriching and harmonizing proprietary and external data and delivering it in an AI-ready environmentFull story -
VIB Accelerates Therapeutic Biologics Discovery with Geneious Biologics
Nov 15, 2018, 06:53 AM by Michael CroftAUCKLAND CITY, NEW ZEALAND - Nov 12, 2018 - VIB Accelerates Therapeutic Biologics Discovery with Geneious BiologicsFull story
AUCKLAND, NZ - November 12, 2018 - Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been chosen by the VIB (a Life Sciences Research Institute in Belgium) to support therapeutic biologics discovery at its Discovery Sciences group -
Quanticate Sponsors Research into Response-Adaptive Trial Design
Nov 15, 2018, 05:59 AM by Michael CroftLONDON, UK - Nov 16, 2018 - LONDON (UK) - Quanticate, a data-focused clinical research organisation (CRO), has announced that it is partnering with Lancaster University to sponsor a STOR-i PhD projectFull story -
Pharma Integrates brings key opinion leaders together to shape the future of healthcare
Nov 15, 2018, 05:31 AM by Michael CroftLONDON, UK - Nov 15, 2018 - Pharma Integrates 2018, which took place earlier this week, attracted more than 350 key industry experts to discuss, debate and share insights on critical challenges in the pharmaceutical industryFull story -
BOC Sciences Releases Pharmaceutical Intermediates to Meet Unmet Needs in the Marketplace
Nov 15, 2018, 03:51 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Nov 15, 2018 - The worlds leading chemical supplier BOC Sciences announced to release varieties of intermediates that are ready to use for the pharmaceutical and scientific communityFull story -
Equus Compute Solutions Announces Release of G4760 4U 10xGPU Server
Nov 14, 2018, 15:59 PM by Michael CroftEDINA, MN, US - Nov 14, 2018 - Equus Compute Solutions Announces Release of G4760 4U 10xGPU Server Server offers high performance for enterprise-level AI and deep learning applicationsEquus Compute Solutions announces the release of its new G4760 4U 10xGPU server, ideal for artificial intelligence and deep learning environmentsFull story -
Frost & Sullivan Recognizes Linguamatics as Artificial Intelligence Life Sciences Leader for their Transformative NLP Text Analytics Platform
Nov 14, 2018, 13:06 PM by Michael CroftCAMBRIDGE, UNITED STATES - Nov 14, 2018 - Based on its recent analysis of the global natural language processing (NLP) in life sciences Artificial Intelligence (AI) market, Frost & Sullivan recognizes Linguamatics with the 2018 Global Product Leadership Award for its industry-leading I2E NLP text mining platformFull story -
Did IBM overhype Watson Healths AI promise?
Nov 14, 2018, 10:19 AM by Michael CroftComputerworld | IBM's Watson Health division has been under fire for not delivering on its promise to use AI to enable smarter, more personalized medicine. But IBM officials maintain that hospitals are seeing benefits.Full story -
Celgene Doubles Down on Dragonfly Pays $50M to Expand Cancer Pact
Nov 14, 2018, 10:17 AM by Michael CroftXconomy | Celgene's collaboration with Dragonfly Therapeutics is less than 18 months old, but the pharmaceutical company is already expanding the alliance. CelgeneFull story -
US FDA Awards Certara’s Simcyp Division Two New Dermal Virtual Bioequivalence Grants
Nov 14, 2018, 09:49 AM by Michael CroftPRINCETON, NJ - Nov 14, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced that it has been awarded two new dermal virtual bioequivalence grants by the US Food and Drug Administration (FDA)Full story -
1CellBio and the Open Medicine Institute Join Forces to Demonstrate Power of Single-Cell RNA Sequencing in Precision Medicine Applications
Nov 13, 2018, 10:00 AM by Michael CroftCAMBRIDGE, MA - Nov 13, 2018 - 1CellBio Inc., a leading single-cell analysis company serving the biomedical research community, today announced a partnership agreement with the Open Medicine Institute (OMI), a leading independent precision medicine clinical and research organizationFull story -
Ardena cements growth and expansion with new HQ
Nov 13, 2018, 05:10 AM by Michael CroftGENT, BELGIUM - Nov 13, 2018 - Contract development and manufacturing organisation (CDMO) Ardena has cemented a sustained period of growth with a move to expanded headquarters in Gent, BelgiumFull story -
Quanticate Expands Presence in India with New Mumbai Office and Appointment of Senior VP and Head Of India
Nov 13, 2018, 03:38 AM by Michael CroftLONDON, UK - Nov 1, 2018 - LONDON (UK) - Quanticate, a leading global data-focused clinical research organisation (CRO), has announced that it has expanded into the Mumbai area with the opening of a new office and the appointment of Dr Sundar Ramamoorthy as the company's senior VP and head of IndiaFull story -
Creative Diagnostics Launches ALK Pathway for Immunology Researchers
Nov 11, 2018, 22:49 PM by Michael CroftSHIRLEY, NY, UNITED STATES - Nov 13, 2018 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics has launched Full storyMR Solutions shows new state-of-the-art bench top CT preclinical scanner with clip on PET and SPECT at nuclear medicine congress
Nov 9, 2018, 16:12 PM by Michael CroftGUILDFORD, UNITED KINGDOM - Nov 9, 2018 - MR Solutions continues to expand its range of preclinical scanners with the first showing of its elegant bench top CT scannerFull storyCertara’s Evidence, Value & Access Specialists to Host Symposium on Automation in Public Health Decision-making and Present 18 Posters at ISPOR Europe
Nov 8, 2018, 15:10 PM by Michael CroftPRINCETON, NJ - Nov 8, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced that its Evidence, Value & Access team will host an educational symposium and present 18 research posters at ISPOR Europe 2018Full storyRecord Growth at The Wasdell Group
Nov 8, 2018, 10:00 AM by Michael CroftNEWCASTLE UPON TYNE, UNITED KINGDOM - Nov 8, 2018 - The Wasdell Group (Wasdell), a leading outsourcing partner for the pharmaceutical, medical device and clinical development and manufacturing industries, has experienced over 40% revenue growth in the last 24 months, following an increase in demand for its clinical trial, manufacturing and packing servicesFull storyRho Announces Kristen Harrington’s Appointment to President of Southeast SAS® Users Group (SESUG)
Nov 8, 2018, 09:31 AM by Michael CroftCHAPEL HILL - Nov 8, 2018 - For Immediate Release Rho Announces Kristen Harrington's Appointment to Presidentof Southeast SAS® Users Group (SESUG) Chapel Hill, NC ̶ November 8, 2018 Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced that Principal Programmer/Analyst and Statistical Programming Operational Service Lead Kristen Harrington has been appointed to President of SESUG, a Regional Users Group (RUG) for users of SAS® SoftwareFull storyMachine Learning Predicts How DNA Breaks Under CRISPR
Nov 8, 2018, 08:25 AM by Michael CroftFull storyBio-IT World | In a study published yesterday in Nature, researchers created a machine-learning model—inDelphi—that predicts how human and mouse cells will respond to CRISPR-induced breaks in DNA.